Business Context and Reporting Period
Company: The Ensign Group, Inc. (ENSG)
Filing Type: Form 8-K (Current Report)
Date of Report: February 1, 2024
Reporting Period: Fourth quarter and full year ended December 31, 2023.
Business Overview: The Company operates in healthcare services, including a real estate segment (Standard Bearer). This filing serves to announce the issuance of a press release containing financial results for the specified period.
Key Financial Metrics
The provided text is a cover report referencing a press release (Exhibit 99.1) and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing defines the following non-GAAP financial measures used in the referenced press release:
- Adjusted Net Income & Adjusted EPS: Supplemental measures excluding specific infrequent or variable items.
- EBITDA: Net income before other income/expense, income taxes, and depreciation/amortization.
- Adjusted EBITDA: EBITDA further adjusted for stock-based compensation, acquisition costs, new systems implementation, litigation, and gains on asset sales.
- Adjusted EBITDAR: Adjusted EBITDA further adjusted for rent-cost of services (noted as a valuation measure, not a performance measure).
- Adjusted EBT: Income before taxes adjusted for stock-based compensation, acquisition costs, systems implementation, litigation, asset sale gains, deferred financing fees, and patient base intangible amortization.
- Funds from Operations (FFO): Segment income for the real estate segment excluding depreciation and amortization related to real estate.
Material Changes
The filing text does not provide specific data regarding material changes in financial performance compared to prior periods. It only confirms that results for the fourth quarter and year ended December 31, 2023, have been reported in a separate press release.
Guidance, Outlook, and Risks
Management Commentary: Management states that the presentation of non-GAAP measures provides important supplemental information to evaluate operating performance. They believe these measures have substance because excluded items are infrequent, variable, or do not represent current cash expenditures.
Risks and Limitations:
- Non-GAAP measures may not be comparable to similar measures used by other companies in the industry.
- These measures should not be relied upon to the exclusion of GAAP financial measures (Net Income and Diluted EPS).
- Adjusted EBITDAR excludes rent expense, which is a normal and recurring operating expense.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 1, 2024) for actual revenue, net income, and EPS figures.
- Verify the reconciliation tables between GAAP Net Income and the defined non-GAAP measures (Adjusted EBITDA, Adjusted EBT, etc.).
- Check the Company's Form 10-K and 10-Q filings for detailed risk factors and historical comparisons.
- Confirm the specific impact of "litigation" and "acquisition related costs" on the adjusted metrics.